KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Construction in Progress (2016 - 2024)

Historic Construction in Progress for Eli Lilly (LLY) over the last 13 years, with Q4 2024 value amounting to $8.2 billion.

  • Eli Lilly's Construction in Progress rose 6216.83% to $8.2 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $8.2 billion, marking a year-over-year increase of 6216.83%. This contributed to the annual value of $8.2 billion for FY2024, which is 6216.83% up from last year.
  • Per Eli Lilly's latest filing, its Construction in Progress stood at $8.2 billion for Q4 2024, which was up 6216.83% from $5.1 billion recorded in Q4 2023.
  • Eli Lilly's Construction in Progress' 5-year high stood at $8.2 billion during Q4 2024, with a 5-year trough of $2.1 billion in Q4 2020.
  • In the last 5 years, Eli Lilly's Construction in Progress had a median value of $2.8 billion in 2022 and averaged $4.1 billion.
  • Per our database at Business Quant, Eli Lilly's Construction in Progress surged by 182.35% in 2021 and then skyrocketed by 8166.58% in 2023.
  • Eli Lilly's Construction in Progress (Quarter) stood at $2.1 billion in 2020, then increased by 1.82% to $2.2 billion in 2021, then increased by 28.51% to $2.8 billion in 2022, then soared by 81.67% to $5.1 billion in 2023, then skyrocketed by 62.17% to $8.2 billion in 2024.
  • Its last three reported values are $8.2 billion in Q4 2024, $5.1 billion for Q4 2023, and $2.8 billion during Q4 2022.